Preclinicalin vivoAntitumor Efficacy of Nedaplatin with Gemcitabine against Human Lung Cancer-Reference-Cited by-同舟云学术

Preclinicalin vivoAntitumor Efficacy of Nedaplatin with Gemcitabine against Human Lung Cancer

Published:2001-01 Issue:1 Volume:92 Page:51-58
ISSN:0910-5050
Container-title:Japanese Journal of Cancer Research
language:en
Short-container-title:

Author:

Matsumoto Mitsunobu,Takeda Yukihiro,Maki Hideo,Hojo Kanji,Wada Tohru,Nishitani Yoshinori,Maekawa Ryuji,Yoshioka Takayuki

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.2001.tb01047.x/fullpdf

Reference35 articles.

1. Synthesis of (glycolato-O, O')diammineplatinum (II) and its related complexes;Totani;Chem. Lett.,1986

2. Effect of treatment schedule on antitumor activity of glycolato-O, O' diammineplatinum (II), a new platinum derivative: comparison with cw-diamminedichloroplatinum (II);Suzumura;Anticancer Res.,1989

3. Pharmacokinetic correlation between experimental and clinical effects on human non-small cell lung cancers of cis-diammine glycolatoplatinum (254-S) and cis-diammine dichloroplatinum;Koenuma;Anticancer Res.,1995

4. Nephrotoxicity of a new platinum compound, 254-S, evaluated with rat kidney cortical slices;Kameyama;Toxicol. Lett.,1990

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PEGylated Chitosan Nanoparticles Loaded with Betaine and Nedaplatin Hamper Breast Cancer: In Vitro and In Vivo Studies;ACS Omega;2023-10-25

2. Changes in renal function following nedaplatin‑containing chemotherapy in patients with urothelial carcinoma unfit for cisplatin;Oncology Letters;2018-12-20

3. A Low Psoas Muscle Index before Treatment Can Predict a Poorer Prognosis in Advanced Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy;BioMed Research International;2017

4. Current and future potential of metallo drugs: Revisiting DNA-binding of metal containing molecules and their diverse mechanism of action;Inorganica Chimica Acta;2016-04

5. Pretreatment Neutrophil-to-Lymphocyte Ratio Can Predict the Prognosis in Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy;BioMed Research International;2016